4.5 Article

Biomass fuel use and indoor air pollution in homes in Malawi

期刊

OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
卷 66, 期 11, 页码 777-783

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/oem.2008.045013

关键词

-

资金

  1. Wellcome Trust [080065]

向作者/读者索取更多资源

Background: Air pollution from biomass fuels in Africa is a significant cause of mortality and morbidity both in adults and children. The work describes the nature and quantity of smoke exposure from biomass fuel in Malawian homes. Methods: Markers of indoor air quality were measured in 62 homes (31 rural and 31 urban) over a typical 24 h period. Four different devices were used (one gravimetric device, two photometric devices and a carbon monoxide (HOBO) monitor. Gravimetric samples were analysed for transition metal content. Data on cooking and lighting fuel type together with information on indicators of socioeconomic status were collected by questionnaire. Results: Respirable dust levels in both the urban and rural environment were high with the mean (SD) 24 h average levels being 226 mu g/m(3) (206 mu g/m(3)). Data from real-time instruments indicated respirable dust concentrations were >250 mu g/m(3) for >1 h per day in 52% of rural homes and 17% of urban homes. Average carbon monoxide levels were significantly higher in urban compared with rural homes (6.14 ppm vs 1.87 ppm; p<0.001). The transition metal content of the smoke was low, with no significant difference found between urban and rural homes. Conclusions: Indoor air pollution levels in Malawian homes are high. Further investigation is justified because the levels that we have demonstrated are hazardous and are likely to be damaging to health. Interventions should be sought to reduce exposure to concentrations less harmful to health.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

A Longitudinal, Observational Study of Etiology and Long-Term Outcomes of Sepsis in Malawi Revealing the Key Role of Disseminated Tuberculosis

Joseph M. Lewis, Madlitso Mphasa, Lucy Keyala, Rachel Banda, Emma L. Smith, Jackie Duggan, Tim Brooks, Matthew Catton, Jane Mallewa, Grace Katha, Stephen B. Gordon, Brian Faragher, Melita A. Gordon, Jamie Rylance, Nicholas A. Feasey

Summary: This study describes the causes and long-term outcomes of sepsis in Malawi, finding that disseminated tuberculosis is the dominant cause and receiving antituberculous chemotherapy is associated with improved survival. Late deaths in individuals living with HIV contribute significantly to post-discharge mortality. These findings suggest the need for locally adapted sepsis protocols in sub-Saharan Africa and highlight the importance of considering distinct pathogens and novel treatment strategies.

CLINICAL INFECTIOUS DISEASES (2022)

Article Immunology

Thirteen-Valent Pneumococcal Conjugate Vaccine-Induced Immunoglobulin G (IgG) Responses in Serum Associated With Serotype-Specific IgG in the Lung

Elena Mitsi, Daniella McLenaghan, Asia-Sophia Wolf, Scott Jones, Andrea M. Collins, Angela D. Hyder-Wright, David Goldblatt, Robert S. Heyderman, Stephen B. Gordon, Daniela M. Ferreira

Summary: This study found that immunization with 13-valent pneumococcal conjugate vaccine elicits serotype-specific immunoglobulin G (IgG) responses, with serum IgG levels to correlate with those measured in bronchoalveolar lavage samples, but shows poor immunogenicity against serotype 3 in both sites.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Multidisciplinary Sciences

Innovative vaccine approaches-a Keystone Symposia report

Jennifer Cable, Rino Rappuoli, Elizabeth J. Klemm, Gagandeep Kang, Ankur Mutreja, Gavin J. Wright, Mariagrazia Pizza, Sowmya Ajay Castro, Joseph P. Hoffmann, Galit Alter, Andrea Carfi, Andrew J. Pollard, Florian Krammer, Ravindra K. Gupta, Caroline E. Wagner, Viviane Machado, Kayvon Modjarrad, Lawrence Corey, Peter B. Gilbert, Gordon Dougan, Nicole Lurie, Pamela J. Bjorkman, Christopher Chiu, Elisa Nemes, Stephen B. Gordon, Andrew C. Steer, Thomas Rudel, Catherine A. Blish, John Tyler Sandberg, Kiva Brennan, Keith P. Klugman, Lynda M. Stuart, Shabir A. Madhi, Christopher L. Karp

Summary: The rapid development of COVID-19 vaccines is the result of years of research and collaboration, but access and efficacy issues still exist in low-and-middle-income countries. Addressing these issues requires innovative research, deeper understanding of vaccine protection, and innovative trial designs and models.

ANNALS OF THE NEW YORK ACADEMY OF SCIENCES (2022)

Article Immunology

Hepatitis B Vaccination Impact and the Unmet Need for Antiviral Treatment in Blantyre, Malawi

Alexander J. Stockdale, James E. Meiring, Isaac T. Shawa, Deus Thindwa, Niza M. Silungwe, Maurice Mbewe, Rabson Kachala, Benno Kreuels, Pratiksha Patel, Priyanka Patel, Marc Y. R. Henrion, Naor Bar-Zeev, Todd D. Swarthout, Robert S. Heyderman, Stephen B. Gordon, Anna Maria Geretti, Melita A. Gordon

Summary: A study conducted in Blantyre, Malawi found that infant HBV vaccination has been highly effective in reducing HBsAg prevalence in adults, but some HBsAg-positive adults have an unmet need for antiviral therapy.

JOURNAL OF INFECTIOUS DISEASES (2022)

Article Medicine, General & Internal

AstraZeneca COVID-19 vaccine induces robust broadly cross-reactive antibody responses in Malawian adults previously infected with SARS-CoV-2

Marah G. Chibwana, Thandeka Moyo-Gwete, Gaurav Kwatra, Jonathan Mandolo, Tandile Hermanaus, Thopisang Motlou, Nonkululeko Mzindle, Frances Ayres, Mphatso Chaponda, Godwin Tembo, Percy Mwenechanya, Ndaona Mitole, Chisomo Jassi, Raphael Kamng'ona, Louise Afran, David Mzinza, Henry C. Mwandumba, Stephen B. Gordon, Khuzwayo Jere, Shabir Madhi, Penny L. Moore, Robert S. Heyderman, Kondwani C. Jambo

Summary: This study aimed to assess the dynamics of anti-Spike antibodies in an African adult population with prior SARS-CoV-2 infection and determine the effect of subsequent COVID-19 vaccination. The findings showed that neutralizing antibodies wane within 6 months post-infection, but a single dose of the AstraZeneca COVID-19 vaccine significantly increased antibody levels. Furthermore, the antibodies generated after vaccination demonstrated broad cross-reactivity against multiple variants and had neutralizing potency.

BMC MEDICINE (2022)

Article Immunology

High Intrapulmonary Rifampicin and Isoniazid Concentrations Are Associated With Rapid Sputum Bacillary Clearance in Patients With Pulmonary Tuberculosis

Andrew D. McCallum, Henry E. Pertinez, Aaron P. Chirambo, Irene Sheha, Madalitso Chasweka, Rose Malamba, Doris Shani, Alex Chitani, Jane E. Mallewa, Jamilah Z. Meghji, Jehan F. Ghany, Elizabeth L. Corbett, Stephen B. Gordon, Geraint R. Davies, Saye H. Khoo, Derek J. Sloan, Henry C. Mwandumba

Summary: This study explores the relationship between intrapulmonary drug levels and sputum bacillary clearance in tuberculosis treatment. The results show that higher drug exposure to rifampicin or isoniazid in the epithelial lining fluid is associated with more rapid bacillary elimination. Higher doses of rifampicin and isoniazid may result in sustained high intrapulmonary drug exposure, rapid bacillary clearance, shorter treatment duration, and better treatment outcomes.

CLINICAL INFECTIOUS DISEASES (2022)

Article Public, Environmental & Occupational Health

A secondary data analysis of a cluster randomized controlled trial: improved cookstoves associated with reduction in incidence of low birthweight in rural Malawi

Rebecca Best, Jullita Mvala, Albert Dube, Cynthia Katundu, Fredrick Kalobekamo, Kevin Mortimer, Stephen B. Gordon, Moffat Nyirenda, Amelia Crampin, Estelle McLean

Summary: This study provides evidence that an improved cookstove intervention in rural Malawi may reduce the number of babies born with low birthweight. This finding is supported by additional subset analysis. The intervention appears to decrease the number of infants born prematurely or with intra-uterine growth restriction, indicating that improved cookstoves could be a beneficial maternal health intervention.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2022)

Article Critical Care Medicine

Human Infection Challenge with Serotype 3 Pneumococcus

Ryan E. Robinson, Elena Mitsi, Elissavet Nikolaou, Sherin Pojar, Tao Chen, Jesus Reine, Tinashe K. Nyazika, James Court, Kelly Davies, Madlen Farrar, Partricia Gonzalez-Dias, Josh Hamilton, Helen Hill, Lisa Hitchins, Ashleigh Howard, Angela Hyder-Wright, Maia Lesosky, Konstantinos Liatsikos, Agnes Matope, Daniella McLenaghan, Christopher Myerscough, Annabel Murphy, Carla Solorzano, Duolao Wang, Hassan Burhan, Manish Gautam, Elizabeth Begier, Christian Theilacker, Rohini Beavon, Annaliesa S. Anderson, Bradford D. Gessner, Stephen B. Gordon, Andrea M. Collins, Daniela M. Ferreira

Summary: This study evaluated the colonization ability and safety of Streptococcus pneumoniae serotype 3 (SPN3) in the nasopharynx using a human challenge model. The results showed that colonization rates varied with inoculum doses and isolate types, and colonization may cause mild upper respiratory symptoms.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Article Immunology

Changing Incidence of Invasive Pneumococcal Disease in Infants Less Than 90 Days of Age Before and After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Blantyre, Malawi: A 14-Year Hospital Based Surveillance Study

Marianne Koenraads, Todd D. Swarthout, Naor Bar-Zeev, Comfort Brown, Jacquline Msefula, Brigitte Denis, Queen Dube, Stephen B. Gordon, Robert S. Heyderman, Melissa J. Gladstone, Neil French

Summary: This study examined the burden of invasive pneumococcal disease (IPD) in infants <90 days old in Blantyre, Malawi over a 14-year period and evaluated the impact of the pneumococcal conjugate vaccine (PCV13) on vaccine-serotype IPD in this population. The results showed that vaccine serotypes 1 and 5 were the main cause of IPD in neonates and young infants, both before and after PCV13 introduction.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2022)

Article Medicine, General & Internal

Protocol for a phase IV double-blind randomised controlled trial to investigate the effect of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine on pneumococcal colonisation using the experimental human pneumococcal challenge model in healthy adults (PREVENTING PNEUMO 2)

Konstantinos Liatsikos, Angela Hyder-Wright, Sherin Pojar, Tao Chen, Duolao Wang, Kelly Davies, Christopher Myerscough, Jesus Reine, Ryan E. Robinson, Britta Urban, Elena Mitsi, Carla Solorzano, Stephen B. Gordon, Angela Quinn, Kaijie Pan, Annaliesa S. Anderson, Christian Theilacker, Elizabeth Begier, Bradford D. Gessner, Andrea Collins, Daniela M. Ferreira

Summary: This article summarizes a study protocol for investigating the effect of the 13-valent pneumococcal conjugate vaccine (PCV13) and the 23-valent pneumococcal polysaccharide vaccine (PPV23) on pneumococcal nasopharyngeal colonization. The study will use experimental human pneumococcal challenge to assess acquisition, density, and duration of colonization, as well as immune responses and antigenuria. The primary outcome is to compare the acquisition rate of pneumococcal serotype 3 (SPN3) between vaccinated and unvaccinated groups.

BMJ OPEN (2022)

Article Immunology

Quality of antibody responses by adults and young children to 13-valent pneumococcal conjugate vaccination and Streptococcus pneumoniae colonisation

Asia -Sophia Wolf, Elena Mitsi, Scott Jones, Simon P. Jochems, Lucy Roalfe, Deus Thindwa, James E. Meiring, Jacquline Msefula, Farouck Bonomali, Tikhala Makhaza Jere, Maurice Mbewe, Andrea M. Collins, Stephen B. Gordon, Melita A. Gordon, Daniela M. Ferreira, Neil French, David Goldblatt, Robert S. Heyderman, Todd D. Swarthout

Summary: This study investigates the protective mechanism of childhood pneumococcal conjugate vaccine (PCV) against pneumococcal carriage. The results show no clear relationship between antibody quality and protection from carriage, suggesting that PCV13-driven antibody quality may mature with age and exposure.

VACCINE (2022)

Article Infectious Diseases

Effect of resistance to third-generation cephalosporins on morbidity and mortality from bloodstream infections in Blantyre, Malawi: a prospective cohort study

Rebecca Lester, Patrick Musicha, Kondwani Kawaza, Josephine Langton, James Mango, Helen Mangochi, Winnie Bakali, Oliver Pearse, Jane Mallewa, Brigitte Denis, Sithembile Bilima, Stephen B. Gordon, David G. Lalloo, Christopher P. Jewell, Nicholas A. Feasey

Summary: The study found that resistance to third-generation cephalosporins is associated with increased mortality and longer hospital stays in patients with bloodstream infections in Malawi. It highlights the urgent need for resource allocation towards antimicrobial resistance mitigation strategies in Africa.

LANCET MICROBE (2022)

Correction Medicine, Research & Experimental

Innate and adaptive nasal mucosal immune responses following experimental human pneumococcal colonization (vol 129, pg 4523, 2019)

Simon P. Jochems, Karin de Ruiter, Carla Solorzano, Astrid Voskamp, Elena Mitsi, Elissavet Nikolaou, Beatriz F. Carniel, Sherin Pojar, Esther L. German, Jesus Reine, Alessandra Soares-Schanoski, Helen Hill, Rachel Robinson, Angela D. Hyder-Wright, Caroline M. Weight, Pascal F. Durrenberger, Robert S. Heyderman, Stephen B. Gordon, Hermelijn H. Smits, Britta C. Urban, Jamie Rylance, Andrea M. Collins, Mark D. Wilkie, Lepa Lazarova, Samuel C. Leong, Maria Yazdanbakhsh, Daniela M. Ferreira

JOURNAL OF CLINICAL INVESTIGATION (2022)

Article Respiratory System

Influence of sex, season and environmental air quality on experimental human pneumococcal carriage acquisition: a retrospective cohort analysis

Katerina S. Cheliotis, Christopher P. Jewell, Carla Solorzano, Britta Urban, Andrea M. Collins, Elena Mitsi, Sherin Pojar, Elissavet Nikolaou, Esther L. German, Jesus Reine, Stephen B. Gordon, Simon P. Jochems, Jamie Rylance, Daniela M. Ferreira

Summary: This study investigated the seasonal and environmental factors influencing susceptibility to nasopharyngeal carriage of Streptococcus pneumoniae, and found that male patients had a lower risk of carriage, while cooler temperatures and lower concentrations of fine particulate matter (PM2.5) were associated with higher risk of carriage.

ERJ OPEN RESEARCH (2022)

Article Public, Environmental & Occupational Health

Association between household air pollution and nasopharyngeal pneumococcal carriage in Malawian infants (MSCAPE): a nested, prospective, observational study

Mukesh K. Dherani, Daniel Pope, Terence Tafatatha, Ellen Heinsbroek, Ryan Chartier, Thandie Mwalukomo, Amelia Crampin, Elena Mitsi, Esther L. German, Elissavet Nikolaou, Carla Solorzano, Daniela M. Ferreira, Todd D. Swarthout, Jason Hinds, Kevin Mortimer, Stephen B. Gordon, Neil French, Nigel G. Bruce

Summary: This study aimed to assess the association between exposure to household air pollution and the prevalence and density of S pneumoniae carriage among children. The study found a significant association between household air pollution exposure and the prevalence of nasopharyngeal S pneumoniae carriage, providing empirical evidence for the potential mechanistic association between exposure to household air pollution and childhood pneumonia.

LANCET GLOBAL HEALTH (2022)

暂无数据